A simple decision rule including D-dimer to reduce the need for computed tomography scanning in patients with suspected pulmonary embolism

J Thromb Haemost. 2015 Aug;13(8):1428-35. doi: 10.1111/jth.13011. Epub 2015 Jun 19.

Abstract

Background: An 'unlikely' clinical decision rule with a negative D-dimer result safely excludes pulmonary embolism (PE) in 30% of presenting patients. We aimed to simplify this diagnostic approach and to increase its efficiency.

Methods: Data for 723 consecutive patients with suspected PE were analyzed (prevalence of PE, 22%). After constructing a logistic regression model with the D-dimer test result and items from the Wells' score, we identified the most prevalent combinations of influential items and selected new D-dimer positivity thresholds. The performance was separately validated with data from 2785 consecutive patients with suspected PE.

Results: Three Wells items significantly added incremental value to the D-dimer test: hemoptysis, signs of deep vein thrombosis and 'PE most likely'. Based on the most frequent combinations of these three items, we identified two groups: (i) none of these three items positive (41%); (ii) one or more of these items positive (59%). When applying a 1000 μg/L D-dimer threshold in group 1 and 500 μg/L in group 2, PE could be excluded without CT scanning in 36%, at a false-negative rate of 1.2% (95%, 0.04-3.3%). In the validation set, these proportions were 46% and 1.9% (95% CI, 1.2-2.7%), respectively. Using the conventional Wells score with a normal D-dimer result, these rates were, respectively, 22% and 0.6% (95% CI, 0.10-2.4%).

Conclusion: Combining Wells items with the D-dimer test resulted in a simplified decision rule, which reduces the need for CT scanning in patients with suspected PE. A prospective validation is required before it can be implemented in clinical practice.

Keywords: D-dimer; diagnostic test; pulmonary embolism; tomography scanners, X-ray computed; venous thromboembolism.

Publication types

  • Validation Study

MeSH terms

  • Adult
  • Aged
  • Area Under Curve
  • Biomarkers / blood
  • Comorbidity
  • Decision Support Techniques*
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis*
  • Hemoptysis / diagnosis
  • Hemoptysis / epidemiology
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Netherlands / epidemiology
  • Patient Selection*
  • Predictive Value of Tests
  • Prevalence
  • Pulmonary Embolism / blood
  • Pulmonary Embolism / diagnosis*
  • Pulmonary Embolism / diagnostic imaging
  • Pulmonary Embolism / epidemiology
  • ROC Curve
  • Reproducibility of Results
  • Retrospective Studies
  • Risk Factors
  • Tomography, X-Ray Computed*
  • Venous Thrombosis / diagnosis
  • Venous Thrombosis / epidemiology

Substances

  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D